International audienceThis study aimed to estimate the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection within the staff and student populations of the University of Corsica (France) during the second wave of the epidemic. Methods: A cross-sectional survey was conducted from 23 November 2020 to 31 January 2021. The participants underwent blood sampling using a fingerstick procedure and completed an anonymized questionnaire. Sera were tested for the presence of anti-SARS-CoV-2 IgG (ELISA-S) and, if positive, with an in-house virus neutralization test (VNT). Results: A total of 418 persons were included in the study. The overall seroprevalence was 12.8% (95% confidence interval (CI), 9.8\textendash 16.6...
International audienceBackground We aimed to estimate the seropositivity to anti-SARS-CoV-2 antibodi...
We aimed to report SARS-CoV-2 seroprevalence after the first wave of the pandemic among healthcare w...
International audienceBackground: We aimed to estimate the seroprevalence of SARS-CoV-2 infection in...
International audienceThis study aimed to estimate the seroprevalence of severe acute respiratory sy...
International audienceThe World Health Organisation recommends monitoring the circulation of severe ...
Background: Systematic screening for antibodies against SARS-CoV-2 is a crucial tool for surveillanc...
Abstract Background The World Health Organisation recommends monitoring the circulation of severe ac...
Background and aim: The COVID-19 is an infectious disease caused by the novel coronavirus SARS-CoV-2...
Objectives: A seroprevalence study of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) w...
International audienceBackground We aimed to estimate the seropositivity to anti-SARS-CoV-2 antibodi...
We aimed to report SARS-CoV-2 seroprevalence after the first wave of the pandemic among healthcare w...
International audienceBackground: We aimed to estimate the seroprevalence of SARS-CoV-2 infection in...
International audienceThis study aimed to estimate the seroprevalence of severe acute respiratory sy...
International audienceThe World Health Organisation recommends monitoring the circulation of severe ...
Background: Systematic screening for antibodies against SARS-CoV-2 is a crucial tool for surveillanc...
Abstract Background The World Health Organisation recommends monitoring the circulation of severe ac...
Background and aim: The COVID-19 is an infectious disease caused by the novel coronavirus SARS-CoV-2...
Objectives: A seroprevalence study of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) w...
International audienceBackground We aimed to estimate the seropositivity to anti-SARS-CoV-2 antibodi...
We aimed to report SARS-CoV-2 seroprevalence after the first wave of the pandemic among healthcare w...
International audienceBackground: We aimed to estimate the seroprevalence of SARS-CoV-2 infection in...